Beyond the Basics: Clarifying Biomarker, Tumor, and Liquid (ctDNA) Testing for Colorectal Cancer Patients - Fight Colorectal Cancer

Beyond the Basics

When: Tuesday, July 7 2026

Biomarker testing is transforming colorectal cancer care, but many patients and caregivers are still left asking important questions: What’s the difference between biomarker testing, tumor testing, and liquid biopsy? When is each test used? And how can these results impact treatment decisions and long-term care?

Watch Fight Colorectal Cancer (Fight CRC) for Beyond the Basics, an educational webinar designed to break down the complex world of biomarker testing into clear, actionable information. This session helps participants better understand the role of tissue testing, circulating tumor DNA (ctDNA), minimal residual disease (MRD) testing, and recurrence monitoring throughout the colorectal cancer journey.

Through expert insights and patient-centered education, viewers will learn:

  • The differences between tumor testing, biomarker testing, and liquid biopsy
  • How ctDNA and MRD testing may be used after surgery and during follow-up care
  • Why timely biomarker testing matters for treatment planning and personalized care
  • How to feel more confident advocating for testing and understanding results

Whether you are newly diagnosed, navigating treatment decisions, or monitoring for recurrence, this webinar provides you with the knowledge and tools to make informed decisions and better understand your care.